dalteparin has been researched along with tamoxifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dmitruk, A; Kozlowski, L; Ostrowska, K; Wojtukiewicz, MZ; Zacharski, LR | 1 |
| Garcipérez de Vargas, FJ; Marcos, G; Moyano Calvente, SL | 1 |
1 trial(s) available for dalteparin and tamoxifen
| Article | Year |
|---|---|
Low molecular weight heparin treatment for malignant melanoma: a pilot clinical trial.
Topics: Anticoagulants; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Dacarbazine; Enoxaparin; Feasibility Studies; Glycosaminoglycans; Humans; Melanoma; Neoplasm Staging; Pilot Projects; Radiotherapy, Adjuvant; Remission Induction; Survival Analysis; Tamoxifen; Treatment Outcome | 2003 |
1 other study(ies) available for dalteparin and tamoxifen
| Article | Year |
|---|---|
Pulmonary embolism as a first manifestation of intracardiac extension of an endometrial stromal sarcoma.
Topics: Anticoagulants; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Endometrial Neoplasms; Enoxaparin; Female; Gynecologic Surgical Procedures; Heart Atria; Humans; Iliac Vein; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Pelvic Neoplasms; Pulmonary Embolism; Radiotherapy, Adjuvant; Sarcoma, Endometrial Stromal; Tamoxifen; Thrombosis; Vascular Neoplasms; Vena Cava, Inferior | 2014 |